journal article·2025-03Open access

Herbal Formula Yi‐Fei‐Jie‐Du‐Tang Regulates Epithelial‐Mesenchymal Transition and Vasculogenic Mimicry in Lung Cancer via HIF1A‐Mediated Ferroptosis

Shanshan Wang, Die Yang, Chengjia Yuan, Yang Wu, Qingying Wang, Yongjian Wu, Xiaochun Zhang

Advanced Biology· Volume 9· Issue 3

Abstract

Abstract Traditional Chinese medicine (TCM) Yi‐Fei‐Jie‐Du‐Tang (YFJDT) has shown potential in lung cancer treatment. However, the mechanisms underlying the effects of YFJDT on lung cancer remain unclear. Bioinformatics analysis is conducted to identify potential targets of YFJDT. The impact of YFJDT on hypoxia‐inducible factor 1 alpha (HIF1A), ferroptosis, and vasculogenic mimicry (VM) is investigated using xenograft tumor models and A549 cells. Additionally, A549 cells are stimulated with CoCl2 to mimic the hypoxic microenvironment of the tumor. The role of HIF1A overexpression in modulating ferroptosis is assessed. The effects of HIF1A and ferroptosis on epithelial‐mesenchymal transition (EMT) and VM in vitro are evaluated. Results: YFJDT treatment led to a concentration‐dependent decrease in HIF1A levels in xenograft tumors and A549 cells. Overexpression of HIF1A counteractes the inhibitory effects of YFJDT on proliferation, EMT, and VM in transplanted tumors. Moreover, HIF1A overexpression attenuates YFJDT‐induced lipid peroxidation and iron accumulation, indicating inhibition of ferroptosis in A549 cells. Hypoxia‐induced alterations in EMT markers and VM are reversed by YFJDT but exacerbated by HIF1A overexpression. Molecular docking identified salicylic acid and psoralen as potential components of YFJDT targeting HIF1A. YFJDT exerts anti‐tumor effects in lung cancer by downregulating HIF1A and promoting ferroptosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · Ferroptosis and cancer prognosis · Cancer, Lipids, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oncology Yangzhou Hospital of Traditional Chinese Medicine Yangzhou Jiangsu 225002 China

Clinical Traditional Chinese Medical College Yangzhou University Yangzhou Jiangsu 225002 China

References (29)

Show source-provided references
1. 10.1158/1055-9965.EPI-19-022110.1158/1055-9965.EPI-19-0221 ↗
2. 10.3390/ijms2216866110.3390/ijms22168661 ↗
3. 10.1016/j.semcancer.2023.05.00810.1016/j.semcancer.2023.05.008 ↗
4. 10.1038/s41591-021-01450-210.1038/s41591-021-01450-2 ↗
5. 10.1016/j.lungcan.2020.07.00710.1016/j.lungcan.2020.07.007 ↗
6. 10.6004/jnccn.2021.005810.6004/jnccn.2021.0058 ↗
7. 10.1155/2022/916061610.1155/2022/9160616 ↗
8. 10.1016/j.cytogfr.2022.01.00610.1016/j.cytogfr.2022.01.006 ↗
9. 10.1038/nature2300710.1038/nature23007 ↗
10. 10.1038/nature2429710.1038/nature24297 ↗
11. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
12. 10.1016/j.drup.2022.10091610.1016/j.drup.2022.100916 ↗
13. 10.1186/s12943-022-01530-y10.1186/s12943-022-01530-y ↗
14. 10.1016/j.jep.2023.11630610.1016/j.jep.2023.116306 ↗
15. 10.1038/s41419-021-03682-z10.1038/s41419-021-03682-z ↗
16. 10.1111/jcmm.1695710.1111/jcmm.16957 ↗
17. 10.1016/j.bbrc.2023.05.05710.1016/j.bbrc.2023.05.057 ↗
18. 10.1016/j.cell.2024.03.02110.1016/j.cell.2024.03.021 ↗
19. 10.1172/JCI13755210.1172/JCI137552 ↗
20. 10.1038/s41416-022-01956-710.1038/s41416-022-01956-7 ↗
21. 10.1038/s41418-023-01228-810.1038/s41418-023-01228-8 ↗
22. 10.1053/j.gastro.2020.07.04610.1053/j.gastro.2020.07.046 ↗
23. 10.1016/j.cub.2020.06.08110.1016/j.cub.2020.06.081 ↗
24. 10.1038/s41420-023-01407-z10.1038/s41420-023-01407-z ↗
25. Newton K. · Cell death · 2024 · 187 · 235
26. 10.1007/s00018-023-04907-410.1007/s00018-023-04907-4 ↗
27. 10.3389/fonc.2024.134429010.3389/fonc.2024.1344290 ↗
28. 10.1016/j.celrep.2023.11294510.1016/j.celrep.2023.112945 ↗
29. 10.1016/S0955-0674(00)00194-010.1016/S0955-0674(00)00194-0 ↗